Aclaris Therapeutics (NASDAQ:ACRS) reported its Q4 earnings results on Tuesday, February 27, 2024 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

Aclaris Therapeutics beat estimated earnings by 12.0%, reporting an EPS of $-0.3 versus an estimate of $-0.34.

Revenue was up $9.82 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.07 which was followed by a 1.0% drop in the share price the next day.

Here's a look at Aclaris Therapeutics's past performance:

To track all earnings releases for Aclaris Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.